Docstoc

Molecular Diagnostics Market

Document Sample
Molecular Diagnostics Market Powered By Docstoc
					Global Molecular Diagnostics Market worth $8.1 Billion by 2017


The new market research report “Molecular Diagnostics Market - Technologies (PCR, DNA Sequencing,
Microarray, Spectroscopy), Applications (Virology/Infectious Diseases, Cancer/Oncology, Genetic
Testing) - Global Opportunities, Competitor Analysis & Forecasts to 2017” analyzes and studies the major
market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Browse 130+ market data tables/ figures spread through 391 pages and in-depth TOC of “Molecular
Diagnostics Market - Technologies, Applications - Global Opportunities, Competitor Analysis &
Forecasts to 2017”.
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html
Early buyers will receive 10% customization on reports.

This report studies the global molecular diagnostics market, with forecast to 2017.

Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the
status of a disease. These nucleic acids or proteins, which belong to individual patients or foreign organisms,
help determine a specific therapy, or risk of developing a specific disease, or other health conditions. MDx is the
fastest growing segment within the in-vitro diagnostic (IVD) space, driven by accuracy, high sensitivity, fast
turnaround time, easy workflow, and cost-effective testing. Owing to these factors, the molecular diagnostics
market crossed $4.8 billion in 2011, and is poised to grow at a CAGR of 9.1% in the next five years to reach $8.1
billion.

Molecular diagnostics has applications in infectious disease molecular testing, oncology, blood screening, genetic
testing, DNA fingerprinting (e.g., paternity testing, forensic testing), microbiology, tissue typing, and food
pathogen detection testing. The booming MDx areas are molecular tests for women’s health, oncology, and
organ transplant testing.

Factors like increase in awareness and acceptance of personalized medicine, advancements in molecular
techniques, and increasing investments in proteomics and genomics research will spur the molecular diagnostics
market in the future. Yet, reimbursement issues for non-coded tests and complex regulatory framework will
restrict the growth of this market.

Although the market for molecular diagnostics is fragmented with more than 500 companies, the most prominent
players are Roche Diagnostics (Switzerland), Novartis (Switzerland), Gen-Probe (U.S.), Qiagen (The
Netherlands), Abbott Diagnostics (U.S.), Becton Dickinson (U.S.) and Cepheid (U.S.), to name a few.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish
strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500
companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research
services. They cover thirteen industry verticals, including advanced materials, automotives and transportation,
banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and
beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and
telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge
market intelligence repository. To know more about us and our reports, please visit our
website www.marketsandmarkets.com

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:8
posted:12/26/2012
language:
pages:2
Description: Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportunities, Competitor Analysis & Forecasts to 2017